Holds 2 active US DMFs and 2 valid CEPs for clindamycin, filing since 2004. Its 2024 FDA inspection closed as VAI.
EDQM certificate database
FDA, List of Drug Master Files
Holds 2 active US DMFs and 2 valid CEPs for clindamycin, filing since 2004. Its 2024 FDA inspection closed as VAI.
Holds 2 active US DMFs and 3 valid CEPs for clindamycin, filing since 2017. Its 2024 FDA inspection closed as VAI.
Holds 3 active US DMFs for clindamycin, filing since 1998. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 valid CEPs for clindamycin, filing since 2024. Its 2025 FDA inspection closed as NAI.
Holds one active US DMF for clindamycin, filing since 2010. Its 2023 FDA inspection closed as VAI.
Holds 4 active US DMFs for clindamycin, filing since 2010. Its 2025 FDA inspection closed as VAI.
Holds 3 active US DMFs for clindamycin, filing since 2013.
Holds one active US DMF for clindamycin, filing since 2007.
Holds one valid CEP for clindamycin, filing since 2025.
Holds one active US DMF for clindamycin, filing since 1998.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Clindamycin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free